INTRODUCTION
The innate immune system has an intricate system of receptors called pattern recognition receptors, which have the ability to recognize pathogen-associated molecular patterns (PAMPs) as danger signals. 1 On recognition of their respective ligands, pattern recognition receptors are capable of inducing a variety of innate immune responses. The Toll-like receptors (TLRs) constitute one such family of pattern recognition receptors and are evolutionary conserved transmembrane glycoproteins molecules. 2 At least 13 TLRs have been identified in mammals and they appear to detect distinct microbial components. For example, TLR3, TLR4, TLR7 / 8, and TLR9 recognize double-stranded RNA, lipopolysaccharides, single-stranded RNA / imidazoquinolines, and CpG motifs in bacterial DNA, respectively 3 -6 In bacterial DNA, CpG dinucleotides occur in the expected frequency (1 of 16), whereas in vertebrate DNA, this frequency is suppressed (1 of 64). The cytosine in CpG dinucleotides is often methylated in vertebrate DNA. 7 Thus, the vertebrate immune system has evolved to specifically recognize CpG dinucleotides as a way of detecting the presence of microbial organisms.
Both in vitro and in vivo studies have shown that CpG oligodeoxynucleotide (ODN) are potent activators of the innate immune system in numerous species, including humans, nonhuman primates, mice, cattle, sheep, pigs, horses, dogs, cats, chickens, and fish. 8 -12 However, CpG-specific responses differ from species to species and the differences in responses seem to be related to TLR9 expression in different cell types. For example, in resting human cells, B cells and plasmacytoid dendritic cells (pDCs) are the two cell types that predominantly express TLR9 and are directly activated by CpG ODN. 13 In contrast, in mice, a wide variety of cell types express TLR9 and are activated directly by CpG ODN, including B lymphocytes, monocytes, macrophages, myeloid dendritic cells, natural killer cells, T-regulatory cells, intestinal and pulmonary epithelia, and even mast cells. 14 -17 All of these cell types express functional TLR9 and this explains why CpG ODN is so potent in mice. TLR9 expression in ruminants has been reported recently 18 and appears to have an expression pattern similar to that of humans. We recently reported that sheep LN cells respond well to all three classes of CpG ODN and with higher magnitude than peripheral blood mononuclear cells (PBMCs). 19 However, responses in 
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gut-associated lymphoid tissues to TLR9 ligand stimulation have not been explored in detail.
The intestinal tract is constantly exposed to microbial flora and must have mechanisms in place to prevent unnecessary and potentially damaging immune responses to harmless commensal flora and dietary antigens. Several mechanisms have been proposed, including downregulation of TLR receptor expression in lamina propria macrophages, 20 lack of innate receptor expression (CD14, Fc , Fc , CR3, and CR4) in intestinal macrophages, 21 restricted distribution of TLR expression in intestinal epithelial cells, 22 and modulation of intestinal epithelia cells by commensal microflora. 23 However, whether such regulation of immune responses occurs in Peyer ' s patches (PPs) is not fully understood.
Peyer ' s patches are the primary site where adaptive immune responses are induced in the intestine of ruminants. 24 Given the role of this tissue in the initiation of immune responses and the importance of TLR in the initiation and development of innate and adaptive immune responses, a detailed understanding of how PP cells respond to TLR agonists would provide insights into the regulation of immune responses in intestine. Contractor et al. 25 recently reported that murine PP pDCs, unlike splenic pDCs, were incapable of producing interferon (IFN)-following stimulation with CpG ODN, presumably due to the suppressive effects of interleukin (IL)-10 in the PP environment. Recently, IL-10-secreting B cells with a regulatory role have been described in murine models of chronic intestinal inflammation. 26 We report that PP CD21 + B cells isolated from normal intestinal tissue spontaneously secrete IL-10, which in turn suppresses CpG-induced innate responses.
RESULTS

IFN and IFN secretion is reduced in PP cells stimulated with CpG ODN
We compared IFN responses in ileal PP (IPP), jejunal PPs (JPP), superficial cervical lymph node (scLN), and mesenteric LN (mLN) cells following stimulation with 2 g ml − 1 of CpG ODN. Both scLN and mLN exhibited IFN responses that were significantly higher than in both JPP and IPP cells ( Figure 1a ). The IFN responses were similar in cells from both JPPs and IPPs ( Figure 1a ) .
Stimulation of scLN and mLN cells with CpG ODN resulted in a significantly higher production (5-to10-fold) of IFN than cells from either ileal of jejunal PPs ( Figure 1b ) . However, JPP cells produced significantly more IFN when compared with IPP cells ( Figure 1b ). Thus CpG-induced IFN and IFN secretion by PP cells was significantly reduced compared with LN cells.
We further performed a dose titration experiment using CpG ODN concentrations of 0.66, 2.0, 6.0 and 18.0 g ml − 1 on cells from all tissues tested above for both IFN and IFN and found that the reduced cytokine responses of PP cells are not due to suboptimal CpG ODN concentration (data not shown). Therefore, regardless of the concentration or class of CpG ODN, interferon (IFN and IFN ) responses were significantly lower in PP cells compared with cells isolated from LN and blood.
IL-12 secretion is reduced in PPs stimulated with CpG ODN
It was recently reported that pDC in mouse PPs stimulated with CpG ODN do not produce IFN but secrete significant amounts of IL-12. 25 Therefore, we investigated whether CpG ODN could induce detectable IL-12 secretion in sheep PP cells.
When comparing IL-12 response between the tissues ( Figure 1c 
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than cells isolated from other tissues and followed a trend similar to the IFN and IFN responses.
PPs have a lower frequency of IFN -producing cells
We hypothesized that the reduced IFN response in PPs is a consequence of either a lower frequency or a lack of IFN -secreting cells in the tissue. Therefore, we assessed the frequency of IFNproducing cells in the various tissues using an enzyme-linked immunosorbent spot assay.
A significant number of IFN -secreting cells were detected in IPP following stimulation with CpG ODN compared with medium alone ( Figure 2a ). This response was CpG-specific, as the GpC control did not induce any detectable responses ( Figure  2a ). Similarly, a significant number of IFN -secreting cells were detected in JPPs, PBMCs and mLN cells stimulated with CpG ODN ( Figure 2b -d ) . When comparing between tissues, stimulation with CpG ODN induced a frequency of IFN -secreting cells that was significantly lower in IPP than in all the other tissues ( Figure 2e ). mLN cells had significantly higher IFNsecreting cells than PBMCs and JPPs, whereas PBMCs had a significantly higher frequency of IFN -secreting cells than JPPs following stimulation with CpG ODN ( Figure 2e ). Enzymelinked immunosorbent spot assay analysis of the frequency of IFN-secreting cells was consistent with data for enzyme-linked immunosorbent assay analysis of cytokines ( Figure 1a ).
PPs constitutively express TLR9 mRNA
We reasoned that IPP and JPP cells may lack sufficient TLR9 expression to respond effectively to CpG ODN stimulation. Therefore, we evaluated TLR9 mRNA expression in cells isolated from different tissues. RNA isolated from IPP, JPP, blood, and mLN tissue all expressed significant higher copy numbers ( P < 0.05) of TLR9 than duodenum, jejunum, and colon ( Figure 3a ) . Interestingly, IPP and JPP tissues expressed similar ARTICLES levels of TLR9 mRNA as mLNs and PBMCs. As the CpG stimulation experiments were done with cells suspensions rather than in tissues, we wondered whether TLR9 mRNA expression in those cell suspensions differed from that in intact tissues. As shown in Figure 3b , cell suspensions had significantly higher expression of TLR9 mRNA than intact tissues, but the overall pattern of expression was similar. Thus, these data confirmed that the cells isolated from tissues expressed TLR9 mRNA. Therefore, poor CpG-induced IFN responses in PPs were unlikely due to the lack of TLR9 receptor expression ( Figure 3a and b ).
Role of IL-10 in the regulation of CpG-induced responses in PPs
Kinetics of IL-10 production in PPs . One factor that could contribute to the reduced CpG ODN-induced cytokine responses by PP cells could be the presence of immunoregulatory cytokines, such as IL-10. Therefore, we evaluated the kinetics of IL-10 secretion in cultures of JPP and mLN cells, and in PBMCs at different time points following stimulation with CpG ODN. In PBMC and mLN cultures, significant IL-10 was not detected until after 48 h of stimulation with CpG ODN ( Figure 4a and c ), whereas in JPP cells, significant IL-10 was detected as early as 16 h of culture ( Figure 4b ) . Surprisingly, we observed that unstimulated PP cells produced detectable levels of IL-10, whereas in PBMCs detectable IL-10 production occurred only after CpG ODN stimulation ( Figure 4d ). Therefore, resting PP cells spontaneously secreted IL-10.
IL-10 inhibits CpG-induced IFN production in PPs . The kinetics of IL-10 production indicated that this cytokine was secreted very early in PP cell cultures. We hypothesized that IL-10 may suppress the induction of IFN by CpG ODN. Therefore, we evaluated the effect of neutralizing IL-10 with an anti-IL-10 antibody on the CpG-induced IFN response. The optimal concentration of neutralizing IL-10 antibody was evaluated by a titration experiment, and 1 / 200 dilution of the antibody was found to be optimal (data not shown). As observed previously, CpG ODN (2429) 
CD21 + PP B cells inhibit CpG-induced IFN , IFN , and IL-12 responses
To confirm that CD21 + B cells were responsible for the inhibition of the CpG-induced responses in PP, we depleted CD21 + B cells from JPP cells, and using equivalent numbers of cells, we tested the effect of the depletion on CpG-induced responses. As 
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Further phenotypic characterization of the PP B cells by flow cytometry showed that the IL-10-secreting B cells were CD21 + CD72 + CD11c − CD1b − sIgM − ( Figure 8 ).
DISCUSSION
Our investigations showed that PP CD21 + B cells secrete IL-10, which plays a direct role in the suppression of IFN secretion by PP cells. Moreover, this B-cell population spontaneously secretes IL-10 in the absence of TLR9 stimulation.
In sheep, CD21 + B cells are representative of a naive B-cell population and are mainly CD5 − , CD11b − , CD11c − , and CD62L + . 27 They localize in the B-cell follicles of PPs, LNs, and spleen and are actively recirculating in the blood and lymphatic system. 28 In this study, we found that unstimulated CD72 + CD11c − CD21 + B cells from PPs secrete a high amount of IL-10, whereas unstimulated CD72 + CD11c − CD21 + B cells from blood do not secrete IL-10. This observation suggests that a phenotypically similar B-cell population at a different anatomic location has " acquired " a distinct function. The IL-10-secreting CD21 + B cells in PPs may represent a novel population of B cells analogous to the recently proposed B regs . 26 Typically, B cells are known mainly for producing antibodies, but they have the ability to produce cytokines and function as antigen-presenting cells. It is now known that similar to T cells, the B-cell population consists of distinct subsets capable of performing pathogenic and regulatory functions. 26 B regs have been observed in several murine models of chronic inflammation, including inflammatory bowel disease, but not in normal intestinal tissue. 26 One of the mechanism by which B regs mediate their regulatory functions is through production of the regulatory cytokines IL-10 and transforming growth factor-, which dampen inflammation. 29, 30 Here, we propose a novel B-cell population capable of secreting IL-10 in the steady state and which may perform regulatory functions similar to murine B regs . However, there appears to be a major difference between the two: the proposed sheep PP B regs constitutively occur in normal intestinal tissues in the absence of any known pathology and spontaneously secrete IL-10 in the absence of stimulation. In contrast, murine B regs are associated with chronically inflamed intestinal tissue and are not present in steady state. 30 Further investigations are required to characterize the functions of these sheep PP B regs in vivo .
Our investigation showed that IL-10 directly suppressed IFN responses in PP. IL-10 is an immunoregulatory and anti-inflammatory cytokine. The major known sources of IL-10 are dendritic cells and macrophages. 31, 32 IL-10 can affect a variety of cell types, including monocytes, macrophages, DCs, and neutrophils. It potently inhibits the production of a variety of cytokines (IL-1, IL-6, IL-12, IL-18, and tumor necrosis factor) 33, 34 and chemokines (IL-8, Interferon-inducible protein-10, Macrophage inflammatory protein-3 , and Regulated upon activation, normal T-expressed, and secreted), 35, 36 thereby affecting the recruitment of neutrophils, DCs, and monocytes. IL-10 induces the generation of regulatory T cells that can suppress antigen-specific responses in vivo and in vitro . 37 Significant difference in IL-10 secretion relative to 6 h time point is indicated by * P < 0.1 and * * P < 0.05. U ml − 1 for IL-10 was defined previously by Kwong et al. , 49 as the biological activity of IL-10 is represented by one unit being the reciprocal of the dilution that inhibited IFN by 50 % .
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intestinal inflammation. 38 Our observation that IL-10 inhibited IFN responses is consistent with Contractor et al. , 25 who showed that IL-10 inhibited IFN production in spleen pDCs and also implicated IL-10 in the inability of pDCs from PP to produce IFN , although they did not evaluate the direct effect of IL-10 on PP pDCs. Recently, Monteleone et al. 22 showed that lamina propria DCs failed to secrete IL-12 in response to CpG and this was attributed to inhibitory IL-10 secreted by these cells, and the authors also showed that unlike spleen or LNC, mucosal DCs expressed high levels of TLR2, 3, 4, 5, and 9 but responded poorly to agonists for these TLRs. 22 However, this study did not investigate the effect of IL-10 on IFN secretion in DCs or other cells in PPs. Interferon-, a type I interferon, is known for its role in antiviral defences, but it can also activate innate and adaptive immune responses. 39 IFN , together with IL-12, can induce natural killer cell cytotoxicity and also augment Th1-mediated immunity through innate production of IFN by natural killer cells and CD8 + cells. IFN can also act independently of IL-12 to activate conventional DC (cDC) maturation and cross-presentation and to enhance CD8 + T-cell responses. Therefore, inhibition of IFN in the PP may skew the balance of immune responses from potentially damaging Th1 type responses.
Jejunal PPs but not IPPs are the primary sites where immune responses are initiated in the gut. 24 We would therefore expect that cells from PP would respond to a potent immune activator, e.g., CpG ODN, in a manner similar to other secondary lymphoid tissues, such as LNCs. In the present investigations, we show that CpG-induced responses (IFN , IFN , and IL-12) in PPs are reduced compared with lymph nodes and blood. Our observations are in line with others who have reported that DC from lamina propria do not respond to TLR ligands unlike spleen DCs. 25 These results are not surprising, as the intestine is constantly exposed to bacterial DNA and other PAMPs present in microbial flora and must have mechanisms of preventing unnecessary responses to microbial stimuli. Our findings that cells from PPs respond poorly to CpG ODN with respect to IFN and IFN production despite expressing high levels of TLR9 is consistent with observations by Pedersen et al. , 40 who reported that primary epithelial cells isolated from normal human colon expressed TLR9 mRNA, but were completely unresponsive to CpG-ODN stimulation in vitro . One of the mechanisms that have been proposed for this tolerance is the downregulation of TLR receptors on mucosal immune cells, e.g. TLR4 in lamina propria macrophages. 20 However, we observed abundant TLR9 mRNA expression in both IPPs and JPPs similar to expression in immune cells from LNs and blood. The TLR9 expression profiles in both IPPs and JPPs and mesenteric LNs in our studies are consistent with the TLR profiles reported recently in sheep 18 and in pigs. 41 Taken together, data from our studies and those from others suggest that the low responses of PP cells to CpG ODN were not due to the downregulation of TLR9 receptor. Rather, other mechanisms are involved in downregulating CpGinduced responses.
In sheep and many other species, including humans, two distinct PPs are found in the small intestine, namely JPPs and IPPs, each with their own characteristic development, structure, and function. 42 IPPs consist of a continuous patch in ovine species, which involutes at a young age and is thought to be responsible for the primary generation of B cells, similar to the bursa of Fabricus in avian species. In contrast, JPPs persist in the adult animal and contain M cells with clusters of B cells in the follicleassociated epithelium. 42, 43 The cellular compositions of the PPs are quite different from LNCs and PBMCs. Unlike peripheral LNs, B cells comprise a large proportion of lymphoid cells in 
the PPs (up to 80 % in JPPs and even higher in IPPs) of sheep, 43 whereas the B-cell frequency in PBMCs or LNCs is around 30 -40 % . 19 In our studies, although the responses in PPs were lower than other lymphoid cells, we showed that JPPs but not IPPs secreted the cytokines IFN , IFN , and IL-12 in response to CpG ODN stimulation. This is consistent with the observation that JPPs but not IPPs are inductive sites for immune responses in the intestine. 24 We observed significantly higher levels of IL-10 secretion in IPP than in JPP cells. This may be due to the higher frequency of B cells in IPPs than JPPs, and as shown, these B cells secrete IL-10. The proportion of CD21 + B cells in IPP:JPP is 2:1 as assessed by flow cytometry (data not shown). Thus our results suggest that there may be more IL-10-secreting B regs in IPPs than JPPs, which may play an important role in the inhibition of innate responses in IPPs. Interestingly, our results also showed that IL-12 was produced in a similar manner to IFN in the tested immune tissues (PPs, LNs, and blood) when stimulated with CpG ODN. This observation suggests that IL-12 secretion is also dependent on the frequency of responder cells in the tissues tested. Thus, the CpGresponder cells (presumably " pDC " ) in the PPs have the ability to produce both significant IFN and IL-12 similar to previous studies, 44, 45 although Contractor et al. 25 have reported that pDC from mouse PP failed to secrete IL-12.
The main distinction between our report and other studies focusing on the gut homeostasis and TLR expression is that our study deals with immune cells that are present in PPs. We clearly demonstrated that these PP immune cells were less responsive than their counterpart in other immune compartments. These results suggest that the immune cells in PPs may have regulatory mechanisms to PAMPs independently of IECs. However, we are not excluding the effect of IECs as shown by many studies.
Although IL-10 downregulates IFN responses, several other factors could also regulate PP cell responses to CpG ODN, including (i) additional anti-inflammatory cytokines, such as transforming growth factor-and thymic stromal lymphopoietin contributing to the anti-inflammatory environment; (ii) multiple signals may be required to induce optimal innate immune responses (e.g., multiple TLR, BCR engagement, T-cell and myeloid DC cooperation); (iii) T-regulatory cells working in concert with B-regulatory cells in the intestine to modulate immune responses. However, further investigations are required to determine the mechanisms by which PP disregard PAMPs from commensal microorganisms but induce an immune response to pathogens.
In conclusion, this analysis showed that PP B cells spontaneously secrete IL-10, which " conditions " an anti-inflammatory environment in this tissue leading to poor cytokine responses to TLR9 agonist, CpG ODN. This may represent a strategy by which PPs dampen innate responses to PAMPs in intestinal immune tissues to maintain intestinal immune homeostasis. 
METHODS
Oligodeoxynucleotides
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Isolation of PBMCs, JPPs, IPPs, and LN cells. Blood was collected from the jugular vein of sheep in ethylene diamine tetra-acetic acid-treated VACUTAINER tubes (Becton Dickinson and Company, Mountain View, CA) and PBMCs were isolated using 54 % isotonic PERCOLL (GE Healthcare AB, Piscataway, NJ), as described previously. 46 Sheeps were euthanized and JPPs, IPPs, and scLNs, and mLNs were removed and placed in ice-cold minimum essential medium (MEM, Gibco BRL, Carlsbad, CA) containing the antibiotics 100 IU ml − 1 penicillin, 100 g ml − 1 streptomycin sulfate, and 0.25 g ml − 1 Amphotericin B (Sigma-Aldrich, St Louis, MO). Cells were isolated from LNs by finely mincing tissue with a scalpel, filtering the cell suspension through a 40-m nylon cell strainer (Becton Dickinson Labware, Franklin Lakes, NJ), and washing the cells with Dulbecco ' s phosphate-buffered saline (PBSA) (pH 7.2), as described previously. 24 IPP and JPP cells were also isolated from the same sheep as described previously. 24, 47 Cells were resuspended in AIM-V medium containing 2 % fetal bovine serum.
Tissue culture conditions. Stimulation of PBMCs, JPPs, IPPs, and LN cells was performed in 96-well, round-bottomed plates (Nunc, Naperville, IL) using AIM-V medium (Invitrogen, Carlsbad, CA) supplemented with 2 % fetal bovine serum, 100 IU ml − 1 penicillin, 100 g ml − 1 streptomycin sulfate, 0.25 g ml − 1 Amphotericin B, 2 mm L -glutamine, 50 M 2-mercaptoethanol, and 10 g ml − 1 polymyxin B sulfate (Sigma-Aldrich). For each treatment, 5 × 10 5 cells (PBMCs, JPPs, IPPs, and LNs) were cultured in triplicate wells in 200 l total volume for 48 h at 37 ° C in an atmosphere of 5 % CO 2 and 95 % humidity. Culture supernatants were harvested and stored at − 20 ° C. For CD21 − cells, 3 × 10 5 cells were cultured with CpG ODN or alone in triplicate wells in 200 l total volume. IFN-a , IFN-c , IL-10, and IL-12 . The IFN-, IFN-, IL-10, and IL-12 enzyme-linked immunosorbent assays used in these studies were shown previously to detect ovine and bovine IFN-, IFN-, and IL-12 cytokines as described elsewhere. 46, 48, 49 IFN a enzyme-linked immunosorbent spot assay and neutralization of IL-10. Interferon--secreting cells were detected using an enzyme-linked immunosorbent spot assay. Microtiter nitrocellulose filtration plates (Whatman, Clifton, NJ) were coated overnight with two monoclonal mouse anti-bovine IFN-antibodies (clones IFN-1C6 and IFN-1D10) and were both diluted to 1:1,000. Cultures were incubated for 24 h at 37 ° C in a humidified atmosphere with 5 % CO 2 before removing the cells. Total IFN -secreting cells were detected by first adding biotinylated goat anti-rabbit IgG (H + L chain specific; 1:5,000 dilution; Zymed, South San Fransisco, CA), followed by alkaline phosphatase-conjugated streptavidin (1:1,000 dilution; Jackson Immunoresearch Laboraties, Westgrove, PA), and finally IFN -secreting cells were visualized with 5-bromo-4-chloro-3-indolyl phosphate / nitroblue tetrazolium insoluble alkaline phosphatase substrate (Sigma-Aldrich). Data presented are mean values for replicate samples. To inhibit the action of IL-10, neutralizing mouse anti-bovine IL-10 antibody (Serotec, MCA 2111EL) was added at 1 / 200 dilution with CpG ODN to cell cultures.
ELISA for
Magnetic activated cell sorting. The CD21 + B-cell fraction was isolated as described previously. 50 Briefly, JPPs and PBMCs were stained with mouse anti-bovine antibody (IgG1, AbD Serotec, UK) for 15 min at 4 ° C. The cells were then washed twice with MACS buffer (PBSA, ethylene diamine tetra-acetic acid and 10 % BSA) and followed by centrifugation for 8 min at 440 g . The cells were then stained with goat anti-mouse IgG1 phycoerythrin conjugate (Southern Biotech, Birmingham, AL) for 15 min at 4 ° C and wash as above. The cells were labeled with antiphycoerythrin magnetic beads for 15 min at 4 ° C and eluted through the LC MACS column (Miltenyi Biotec, Bergish Gladbach, Germany) according to the manufacturer ' s instruction. The CD21 + B-cell fraction was eluted, washed in PBSA and resuspended in AIM-V media containing 2 % fetal bovine serum.
Quantitative RT-PCR. Reverse transcrition-PCR was used to quantify TLR9 mRNA in IPPs, JPPs, mLNs, jejunum (small intestine in interspaces between PPs), duodenum, and colon. TLR9 mRNA was also assessed in single-cell suspensions from these tissues (IPPs, JPPs, mLNs, and PBMCs). Total RNA was isolated from all tissues and isolated cell suspensions using TRIZOL reagent (Molecular Research Center, Cincinnati, OH) and DNAse I Amp Grade (Invitrogen). For complementary DNA (cDNA), RNA (1 g) was incubated in a final volume of 15 l with dNTP, oligo dT, RNASEOUT inhibitor (Invitrogen), buffer RT, and SUPERSCRIPT reverse transcriptase (Invitrogen). The reaction was performed according to the manufacturer ' s recommendations. The cDNA generated was either used immediately for qPCR or stored at − 80 ° C. 
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Complementary DNA was combined with primer / probe sets and IQ SYBR Green Supermix (Molecular Probes) according to the manufacturer ' s recommendations. All primers were designed using Clone Manager (Scientific and Educational Software, Cary, NC). TLR9 forward primer 5 Ј CGTGAGCAGCAACAGCATC 3 Ј and reverse primer 5 Ј TAAGCGACCGAACCAGAAGG 3 Ј were purchased from SigmaAldrich. The PCR conditions were 95 ° C for 3 min, followed by 45 cycles with denaturation at 95 ° C for 15 s, annealing temperature at 59 ° C for 30 s, and elongation at 72 ° C for 30 s. Real-time assays were run on a Bio-Rad ICYCLER IQ system (Bio-Rad Laboratories, Hercules, CA). The specificity of the PCRs was assessed by the analysis of the melting curves of the products and size verification and sequencing of the amplicons.
To normalize the amount of cDNA, we sampled equal tissue sizes, quantitated RNA, assessed its quality before reverse transcription, and used a reference gene. Samples were normalized internally using the average cycle threshold ( C t ) of glyceraldehyde-3-phosphate dehydrogenase as a reference in each tissue. To quantify the numbers of copies, plasmid containing sheep TLR9 cDNA were linearized with Xho I (New England Biolabs) and 10 twofold dilutions of the plasmid were used to create a standard curve for the quantification of the RNA-generated cDNA. Values were expressed as transcript copy number per 1 g of total input RNA, which were determined in each sample by interpolation with the respective standard curves. The correlation coefficient of TLR9 standard curve was 0.996. The concentration of the test samples was calculated from the standard curves, according to the formula y = − MC t + B , where M is the slope of the curve, C t is the point during the exponential phase of amplification in which the fluorescent signal is first recorded as being statistically significant above background, and B is the y axis intercept. Only C t values < 40 were used for calculation of the PCR efficiency from the given slope according to the equation: PCR efficiency = (10 [1 / M ] 1) × 100. All PCRs showed efficiency between 94 and 100 % .
Flow cytometry. Monoclonal antibody specific for sheep CD1b (MCA 1646) and CD21 (MCA1424G) were purchased from Serotec and IgM (PIg45A), and CD11c (BAQ153A) were purchased from VMRD (Pullman, WA). CD72 (DU2-104) was produced from hybridomas in house. Fluorescein isothiocyanate-conjugated and phycoerythrin-conjugated, isotype-specific anti-mouse immunoglobulin (Ig) was purchased from Cedarlane Laboratories (Burlington, ON, Canada). Phenotypic analysis was restricted to viable cells, and the level of specific monoclonal 
